Glenmark Pharma Q4 cons PAT Rs 219 cr

Glenmark Pharma has announce its fourth quarter results. The company's Q4 consolidated PAT Rs 219 crore versus Rs 63 crore.

Its consolidated revenues were up at Rs 582 crore versus Rs 339.1 crore.

Its Generic Arm net sales were at Rs 260 crore versus Rs 120 crore.

Particulars	Mar-08	Dec-07	Sep-07	Jun-07
Net Sales / Interest Earned / Operating Income	396.898	433.579	279.267	262.947
Other Income	15.008	2.26	1.694	1.084
Total Income	411.905	435.839	280.961	264.031
Expenditure	-281.439	-238.634	-182.47	-188.434
Operating Profit	130.466	197.205	98.491	75.598
Interest	-9.144	-11.764	-10.871	-9.352
Profit Before Depreciation and Tax	121.322	185.441	87.62	66.246
Depreciation	-8.17	-7.776	-7.506	-5.991
Profit before Tax	113.153	177.665	80.115	60.255
Tax	16.988	-31.238	-16.251	-11.663
Net Profit	130.141	146.427	63.864	48.592
Equity Capital	24.873	24.686	24.394	24.212